tiprankstipranks
Aoyuan Healthy Life Group Co. Ltd. (HK:3662)
:3662
Hong Kong Market
Want to see HK:3662 full AI Analyst Report?

Aoyuan Healthy Life Group Co. Ltd. (3662) AI Stock Analysis

1 Followers

Top Page

HK:3662

Aoyuan Healthy Life Group Co. Ltd.

(3662)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
HK$0.30
▼(-32.73% Downside)
Action:ReiteratedDate:04/27/26
The score is held back primarily by deteriorating financial performance (multi-year revenue decline, margin compression, and a sharp 2025 cash-flow pullback) and bearish technical signals (below all major moving averages, negative MACD, oversold RSI). These risks are partially offset by an attractive valuation profile (low P/E and high dividend yield) and a materially de-risked balance sheet with very low leverage.
Positive Factors
De-risked, low-leverage balance sheet
Very low and falling leverage materially reduces refinancing and solvency risk across real-estate cycles. A stronger capital structure gives the firm flexibility to withstand revenue volatility, fund working capital or small M&A, and maintain operations without heavy financing pressure.
Negative Factors
Multi-year revenue decline
Four consecutive years of revenue decline signal weakening market share, pricing power, or contract wins. Persistent top-line erosion undermines scale advantages, reduces managerial flexibility and makes sustaining margins and investment in service upgrades harder over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
De-risked, low-leverage balance sheet
Very low and falling leverage materially reduces refinancing and solvency risk across real-estate cycles. A stronger capital structure gives the firm flexibility to withstand revenue volatility, fund working capital or small M&A, and maintain operations without heavy financing pressure.
Read all positive factors

Aoyuan Healthy Life Group Co. Ltd. (3662) vs. iShares MSCI Hong Kong ETF (EWH)

Aoyuan Healthy Life Group Co. Ltd. Business Overview & Revenue Model

Company Description
Aoyuan Healthy Life Group Company Limited, through its subsidiaries, provides property management and commercial operational services in the People's Republic of China. The company offers property management services for high-end residence communi...
How the Company Makes Money
The company primarily makes money through (1) property management service fees charged for day-to-day building and estate operations (e.g., security, cleaning, maintenance, customer service and facilities management) under property management cont...

Aoyuan Healthy Life Group Co. Ltd. Financial Statement Overview

Summary
Weak operating trajectory offsets a stronger balance sheet. Revenue has fallen for four straight years (2022–2025) and profitability has compressed (net margin ~10.1% in 2023 to ~4.2% in 2025). Leverage is very low and improving (debt-to-equity ~0.05 in 2025), but cash generation is inconsistent and weakened sharply in 2025 (free cash flow down ~58% YoY).
Income Statement
44
Neutral
Balance Sheet
72
Positive
Cash Flow
36
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.19B1.36B1.56B1.63B1.94B
Gross Profit304.45M385.04M399.62M397.21M469.57M
EBITDA129.18M160.95M198.54M245.27M-108.96M
Net Income50.23M96.22M157.14M160.41M-190.94M
Balance Sheet
Total Assets2.23B2.36B2.28B2.22B2.29B
Cash, Cash Equivalents and Short-Term Investments1.01B1.05B984.50M857.81M1.21B
Total Debt65.29M81.69M114.94M158.29M412.59M
Total Liabilities997.36M1.11B1.13B1.23B1.50B
Stockholders Equity1.21B1.20B1.10B931.48M747.32M
Cash Flow
Free Cash Flow31.62M107.61M93.52M-108.95M-98.54M
Operating Cash Flow37.98M140.33M106.01M-105.68M-86.34M
Investing Cash Flow-1.37M-30.53M67.93M-50.65M31.09M
Financing Cash Flow-69.06M-51.28M-48.34M-272.10M-245.32M

Aoyuan Healthy Life Group Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.44
Price Trends
50DMA
0.38
Negative
100DMA
0.41
Negative
200DMA
0.46
Negative
Market Momentum
MACD
-0.03
Positive
RSI
18.02
Positive
STOCH
43.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3662, the sentiment is Negative. The current price of 0.44 is above the 20-day moving average (MA) of 0.33, above the 50-day MA of 0.38, and below the 200-day MA of 0.46, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 18.02 is Positive, neither overbought nor oversold. The STOCH value of 43.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3662.

Aoyuan Healthy Life Group Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
HK$519.95M6.1411.59%1.82%-2.78%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
56
Neutral
HK$256.01M10.335.84%3.90%-6.82%-26.04%
54
Neutral
HK$210.61M5.654.23%6.60%-9.97%-46.38%
51
Neutral
HK$221.52M-3.79-8.93%15.45%1.07%-1080.00%
43
Neutral
HK$172.80M13.702.10%-6.51%512.50%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3662
Aoyuan Healthy Life Group Co. Ltd.
0.30
-0.22
-42.42%
HK:9608
Sundy Service Group Co. Ltd
0.05
-0.05
-51.09%
HK:2107
First Service Holding Limited
0.17
-0.10
-37.41%
HK:2165
Ling Yue Services Group Limited
1.82
0.49
36.84%
HK:2376
Lushang Life Services Co., Ltd. Class H
1.92
0.48
33.33%

Aoyuan Healthy Life Group Co. Ltd. Corporate Events

Starjoy Wellness and Travel Sets 2026 AGM to Seek Shareholder Mandates on Capital and Governance
Apr 22, 2026
Starjoy Wellness and Travel Company Limited has called its annual general meeting for 22 May 2026 in Hong Kong to review the audited consolidated financial statements for the year ended 31 December 2025 and receive reports from directors and audit...
Starjoy Directors Complete Mandated Training After HKEX Disciplinary Action
Apr 14, 2026
Starjoy Wellness and Travel Company Limited has confirmed that five of its directors, previously subject to disciplinary action by the Hong Kong Stock Exchange for breaches of Listing Rules, have completed 26 hours of mandated training on regulato...
Starjoy Wellness and Travel Resets Use of IPO Proceeds, Extends Deployment to 2028
Apr 10, 2026
Starjoy Wellness and Travel has reallocated and extended the timeline for using the remaining HK$136.4 million of net proceeds raised from its 2019 Hong Kong listing and subsequent over-allotment option, after having already deployed about RMB436....
Starjoy Wellness and Travel Profit Falls as Competition and Impairments Weigh on 2025 Results
Mar 27, 2026
Starjoy Wellness and Travel Company Limited reported a challenging 2025, with total revenue falling about 10% to RMB1.22 billion and gross profit slipping to RMB313 million, compressing its gross margin to 25.6%. The company cited weaker exchange ...
Starjoy Wellness and Travel Sets Board Meeting to Approve 2025 Results and Mull Final Dividend
Mar 17, 2026
Starjoy Wellness and Travel Company Limited has scheduled a board meeting for 27 March 2026 to review and approve the group’s annual results for the financial year ended 31 December 2025 and to authorise their public release. The board will ...
Starjoy Wellness and Travel Reshapes Top Leadership After Key Resignations
Mar 16, 2026
Starjoy Wellness and Travel Company Limited announced a significant reshuffle of its board and senior leadership, with long-serving chairman, executive director and group president Mr. Wang Jiren resigning from all his roles, including committee c...
Starjoy Wellness and Travel Sets Out Board and Committee Structure
Mar 16, 2026
Starjoy Wellness and Travel Company Limited has announced the composition of its board, naming Ms. Liang Jinrong as chairman and chief financial officer alongside executive director Mr. Tao Yu, with additional oversight provided by non-executive a...
Starjoy flags sharp 2025 profit drop but says core earnings steady
Mar 13, 2026
Starjoy Wellness and Travel Company Limited has warned that its profit for 2025 will drop sharply, with expected net profit of about RMB45 million to RMB50 million versus RMB86.3 million a year earlier, and profit attributable to owners falling to...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 27, 2026